Ozempic, Wegovy have health benefits beyond weight loss, studies find
New trials are showing how the blockbuster diabetes and weight-loss meds Ozempic and Wegovy can boost health in even more ways.
Aug 30, 2024
0
2
New trials are showing how the blockbuster diabetes and weight-loss meds Ozempic and Wegovy can boost health in even more ways.
Aug 30, 2024
0
2
New Cleveland Clinic and Tufts University research shows that elevated levels of the gut microbiome trimethylamine N-oxide (TMAO) pathway led to a higher risk of heart failure independent of other risk factors, according ...
Aug 14, 2024
0
2
Patients with congestive heart failure (CHF) having a compromised blood supply, are at greater risk of sudden cardiac death (SCD). With an estimated incidence as high as 22% among these patients, current clinical guidelines ...
Jul 29, 2024
0
0
Prescribing non-steroidal anti-inflammatory drugs (NSAIDs) to people at high risk of harm from them is estimated to cost the NHS in England around £31 million and cause more than 6,000 lost years of good health over 10 years, ...
Jul 24, 2024
0
0
New research shows combined use of sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP1-RAs) is likely to offer additional protection against heart and kidney disease in ...
Jul 8, 2024
0
42
Fewer than one-quarter of patients with type 2 diabetes (T2D) receive recommended chronic kidney disease (CKD) screening, according to a study published online June 26 in JAMA Network Open.
Jul 1, 2024
0
0
From "breathwork recipes" to breathing techniques, many social media and health websites are recommending breathwork to reduce stress.
Jun 25, 2024
0
2
The triglyceride-glucose (TyG) index is independently associated with all-cause mortality among patients with heart failure and chronic kidney disease (CKD), according to a study published online June 12 in ESC Heart Failure.
Jun 21, 2024
0
0
Osteoarthritis is the most common arthritis worldwide, and has an increasing global burden of disability and health care utilization. It is also associated with various comorbidities, and this link has gained attention in ...
Jun 14, 2024
0
1
The U.S. Food and Drug Administration on Friday has for the first time approved the use of a respiratory syncytial virus (RSV) vaccine for people in their 50s who are at increased risk for the illness.
Jun 10, 2024
0
0